Ledger.Open graph →
SEC Form D · filed August 29, 2014

Civitas Therapeutics, Inc

Offering
$55.3M
Sold
$55.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CHELSEA, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Bryan Stuart · CHELSEA, MAExecDavid Hirsch · Pittsburgh, PADirectorMartin Freed · CHELSEA, MAExecAndrea Franz · Waltham, MAExecMary Taylor · CHELSEA, MAExecRob Hopfner · San Francisco, CADirectorBlair Jackson · CHELSEA, MADirectorBryan Stuart · Cambridge, MAExecTimothy S. Nelson · CHELSEA, MADirectorRajeev S. Shah · CHELSEA, MADirectorMark Iwicki · CHELSEA, MAExec · DirectorRichard Batycky · CHELSEA, MAExecTim S. Shannon · CHELSEA, MADirectorGlenn Batchelder · CHELSEA, MADirectorDavid Hirsch · New York, NYDirectorMartin Freed · Cambridge, MAExecRobert S. Roche · CHELSEA, MADirectorAidan King · CHELSEA, MADirectorAndrea Franz · Concord, NHExecMary Taylor · Needham, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗